Inventor · disambiguated record
Andreas Muhs
Also filed as: MUHS ANDREAS
36 granted patents·30 pending applications·324 citations·filing 2006–2025
97Inventor score
Top patents by PatentIndex Score
66 records- 0197US7892544B2Humanized anti-beta-amyloid antibodyAC IMMUNE SA·Filed 2007·Granted Feb 22, 2011·55 cites·26 claims
- 0296US7772375B2Monoclonal antibodies that recognize epitopes of amyloid-betaAC IMMUNE SA·Filed 2006·Granted Aug 10, 2010·51 cites·15 claims
- 0394US9585956B2Polynucleotides encoding anti-amyloid beta monoclonal antibodiesAC IMMUNE SA·Filed 2015·Granted Mar 7, 2017·8 cites·21 claims
- 0494US8246954B2Methods of treating amyloidosis with humanized anti-beta-amyloid antibodiesPFEIFER ANDREA·Filed 2009·Granted Aug 21, 2012·24 cites·57 claims
- 0593US9175094B2Monoclonal antibodyAC IMMUNE SA·Filed 2013·Granted Nov 3, 2015·9 cites·36 claims
- 0693US8124353B2Methods of treating and monitoring disease with antibodiesPFEIFER ANDREA·Filed 2007·Granted Feb 28, 2012·20 cites·11 claims
- 0792US11124552B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Sep 21, 2021·8 cites·14 claims
- 0892US8796439B2Nucleic acid molecules encoding a humanized antibodyPFEIFER ANDREA·Filed 2012·Granted Aug 5, 2014·15 cites·47 claims
- 0991US10836817B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2019·Granted Nov 17, 2020·10 cites·22 claims
- 1091US8647631B2Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell linesPFEIFER ANDREA·Filed 2010·Granted Feb 11, 2014·16 cites·15 claims
- 1190US8048420B2Monoclonal antibodyAC IMMUNE SA·Filed 2008·Granted Nov 1, 2011·12 cites·36 claims
- 1288US11591377B2Heterologous administration of tau vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·20 claims
- 1388US9304138B2Pharmaceutical compositionPFEIFER ANDREA·Filed 2011·Granted Apr 5, 2016·12 cites·27 claims
- 1487US11684576B2Method of safe administration of phosphorylated tau peptide vaccineAC IMMUNE SA·Filed 2020·Granted Jun 27, 2023·2 cites·20 claims
- 1585US9221812B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsKROTH HEIKO·Filed 2011·Granted Dec 29, 2015·15 cites·18 claims
- 1685US8613923B2Monoclonal antibodyPFEIFER ANDREA·Filed 2008·Granted Dec 24, 2013·7 cites·12 claims
- 1784US10100104B2Methods of diagnosing tau-protein-associated diseaseUNIV LEUVEN KATH·Filed 2016·Granted Oct 16, 2018·4 cites·26 claims
- 1884US10066010B2Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising TauAC IMMUNE SA·Filed 2016·Granted Sep 4, 2018·4 cites·14 claims
- 1984US9403902B2Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibodyPFEIFER ANDREA·Filed 2008·Granted Aug 2, 2016·7 cites·9 claims
- 2084US9146244B2Polynucleotides encoding an anti-beta-amyloid monoclonal antibodyPFEIFER ANDREA·Filed 2011·Granted Sep 29, 2015·6 cites·37 claims
- 2182US9540434B2Phosphospecific antibodies recognising tauAC IMMUNE SA·Filed 2012·Granted Jan 10, 2017·5 cites·17 claims
- 2281US9657091B2Humanized tau antibodyAC IMMUNE SA·Filed 2013·Granted May 23, 2017·5 cites·22 claims
- 2379US12324855B2Method of safe administration of phosphorylated Tau peptide vaccineAC IMMUNE SA·Filed 2023·Granted Jun 10, 2025·0 cites·20 claims
- 2479US2023338535A1Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune ResponsesJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2578US9687447B2Method for preparing liposome-based constructsREIS PEDRO·Filed 2011·Granted Jun 27, 2017·8 cites·3 claims
- 2678US9598485B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2014·Granted Mar 21, 2017·4 cites·66 claims
- 2776US9221900B2Methods for identifying safe and functional humanized antibodiesPFEIFER ANDREA·Filed 2011·Granted Dec 29, 2015·3 cites·26 claims
- 2875US9701660B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemAC IMMUNE SA·Filed 2014·Granted Jul 11, 2017·2 cites·8 claims
- 2975US2025134973A1Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune ResponsesJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3073US8916590B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemKROTH HEIKO·Filed 2010·Granted Dec 23, 2014·2 cites·13 claims
- 3173US2025275920A1Method of Safe Administration of Phosphorylated TAU Peptide VaccineAC IMMUNE SA·Filed 2025·Application pending·0 cites
- 3272US9289488B2Vaccine engineeringHICKMAN DAVID·Filed 2011·Granted Mar 22, 2016·3 cites·18 claims
- 3370US11958889B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Apr 16, 2024·0 cites·24 claims
- 3470US8673940B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsFROESTL WOLFGANG·Filed 2012·Granted Mar 18, 2014·4 cites·7 claims
- 3569US2023257433A1Heterologous Administration of Tau VaccinesJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3668US2010297132A1Monoclonal antibodyAC IMMUNE SA·Filed 2009·Application pending·0 cites
- 3767US10500207B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted Dec 10, 2019·1 cites·18 claims
- 3867US2021317197A1Humanized antibodyAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 3967US2025144212A1Liposomes containing phosphorylated tau peptides for inducing sustained immune responsesJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4067US2024270829A1Vaccine TherapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 4166US10758876B2Stirring tool and stirrer comprising a tool of said typeSAMIX GMBH·Filed 2019·Granted Sep 1, 2020·0 cites·20 claims
- 4265US2022227847A1Humanized antibodyAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 4364US2020055928A1Humanized antibodyAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 4463US11352419B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2020·Granted Jun 7, 2022·0 cites·15 claims
- 4562US2009155249A1Humanized antibody igg1GENENTECH INC·Filed 2008·Application pending·0 cites
- 4659US8613906B2Treatment of ischemia using stem cellsMUHS ANDREAS·Filed 2006·Granted Dec 24, 2013·0 cites·17 claims
- 4759US2015259406A1Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell LinesAC IMMUNE SA·Filed 2014·Application pending·0 cites
- 4859US2018327485A1Humanized antibodyAC IMMUNE SA·Filed 2017·Application pending·0 cites
- 4958US2012288896A1Nucleic acid molecules encoding anti-amyloid-beta antibodiesGREFERATH RUTH·Filed 2012·Application pending·0 cites
- 5058US2012244165A1Methods of treating amyloidosis comprising the use of anti-amyloid beta antibodiesGREFERATH RUTH·Filed 2012·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andreas Muhs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →